233 related articles for article (PubMed ID: 26006028)
1. Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms.
Wang X; Wang N; Cheung F; Lao L; Li C; Feng Y
J Integr Med; 2015 May; 13(3):142-64. PubMed ID: 26006028
[TBL] [Abstract][Full Text] [Related]
2. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
[TBL] [Abstract][Full Text] [Related]
3. Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.
Ting CT; Li WC; Chen CY; Tsai TH
J Chin Med Assoc; 2015 Mar; 78(3):139-44. PubMed ID: 25447209
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition.
Li JJ; Liang Q; Sun GC
J Integr Med; 2021 Nov; 19(6):469-477. PubMed ID: 34538644
[TBL] [Abstract][Full Text] [Related]
5. Preventive and Therapeutic Effects of Chinese Herbal Compounds against Hepatocellular Carcinoma.
Hu B; An HM; Wang SS; Chen JJ; Xu L
Molecules; 2016 Jan; 21(2):142. PubMed ID: 26828466
[TBL] [Abstract][Full Text] [Related]
6. Traditional Chinese medicine targeting cancer stem cells as an alternative treatment for hepatocellular carcinoma.
Tang KY; Du SL; Wang QL; Zhang YF; Song HY
J Integr Med; 2020 May; 18(3):196-202. PubMed ID: 32067923
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer.
Zhang Y; Guan DX; Shi J; Gao H; Li JJ; Zhao JS; Qiu L; Liu J; Li N; Guo WX; Xue J; Zhou FG; Wu MC; Wang HY; Xie D; Cheng SQ
J Hepatol; 2013 Dec; 59(6):1255-63. PubMed ID: 23867314
[TBL] [Abstract][Full Text] [Related]
8. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
Bishayee A; Politis T; Darvesh AS
Cancer Treat Rev; 2010 Feb; 36(1):43-53. PubMed ID: 19910122
[TBL] [Abstract][Full Text] [Related]
10. Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.
Chen SR; Qiu HC; Hu Y; Wang Y; Wang YT
Phytother Res; 2016 Jun; 30(6):863-77. PubMed ID: 26879574
[TBL] [Abstract][Full Text] [Related]
11. Chemical composition of total flavonoids from Salvia chinensia Benth and their pro-apoptotic effect on hepatocellular carcinoma cells: potential roles of suppressing cellular NF-κB signaling.
Xiang M; Su H; Hu Y; Hu Y; Yang T; Shu G
Food Chem Toxicol; 2013 Dec; 62():420-6. PubMed ID: 24036141
[TBL] [Abstract][Full Text] [Related]
12. Selenium in the prevention and treatment of hepatocellular carcinoma.
Darvesh AS; Bishayee A
Anticancer Agents Med Chem; 2010 May; 10(4):338-45. PubMed ID: 20380634
[TBL] [Abstract][Full Text] [Related]
13. Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds.
Hong M; Tan HY; Li S; Cheung F; Wang N; Nagamatsu T; Feng Y
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338343
[TBL] [Abstract][Full Text] [Related]
14. Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma.
Liu C; Yang S; Wang K; Bao X; Liu Y; Zhou S; Liu H; Qiu Y; Wang T; Yu H
Biomed Pharmacother; 2019 Dec; 120():109543. PubMed ID: 31655311
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
Jayachandran A; Dhungel B; Steel JC
J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
[TBL] [Abstract][Full Text] [Related]
17. A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.
Yamashita M; Wada H; Eguchi H; Ogawa H; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Umeshita K; Doki Y; Mori M
Int J Oncol; 2016 Jul; 49(1):89-98. PubMed ID: 27121124
[TBL] [Abstract][Full Text] [Related]
18. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
[TBL] [Abstract][Full Text] [Related]
19. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
Frau M; Biasi F; Feo F; Pascale RM
Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
Chen G; Wang K; Yang BY; Tang B; Chen JX; Hua ZC
Int J Oncol; 2012 Jan; 40(1):139-47. PubMed ID: 21947421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
